Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$24.71 USD
-0.31 (-1.24%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $24.77 +0.06 (0.24%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Price, Consensus and EPS Surprise
ANIK 24.71 -0.31(-1.24%)
Will ANIK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ANIK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ANIK
Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
ANIK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
Other News for ANIK
Anika Therapeutics Inc (ANIK) Stock Price Up 4.14% on Sep 17
Caligan Partners LP Bolsters Portfolio with Significant Stake in Liquidia Corp
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Politan Provides Update on Why Masimo Shareholders Should Support Urgently Needed Board Change at Company?s 2024 AGM
ANIK Makes Notable Cross Below Critical Moving Average